Thus, it is necessary to carefully follow up for recurrence after curative treatment for HCC using image inspection and laboratory data, especially in patients with high AFP level and multiple occurrences of HCC before the DAA therapy. The gene discussed is AFP; the disease is hepatocellular carcinoma.